Clinical relevance of contrast-enhanced ultrasound in monitoring anti-angiogenic therapy of cancer: current status and perspectives.

[1]  Kinuyo Hatanaka,et al.  Differential Diagnosis of Hepatic Tumors: Value of Contrast-Enhanced Harmonic Sonography Using the Newly Developed Contrast Agent, Sonazoid , 2008, Intervirology.

[2]  P. Vrignaud,et al.  Early Quantitative Evaluation of a Tumor Vasculature Disruptive Agent AVE8062 Using Dynamic Contrast-Enhanced Ultrasonography , 2008, Investigative radiology.

[3]  Sanjiv S Gambhir,et al.  US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. , 2008, Radiology.

[4]  T. Yankeelov,et al.  Measuring Tumor Perfusion in Control and Treated Murine Tumors , 2007, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[5]  D. Cosgrove,et al.  WFUMB Safety Symposium on Ultrasound Contrast Agents: clinical applications and safety concerns. , 2007, Ultrasound in medicine & biology.

[6]  Katherine W Ferrara,et al.  Quantitative contrast enhanced ultrasound and CT assessment of tumor response to antiangiogenic therapy in rats. , 2007, Ultrasound in medicine & biology.

[7]  G. Parker,et al.  DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents , 2007, British Journal of Cancer.

[8]  Rolf A. Brekken,et al.  Monitoring Response to Anticancer Therapy by Targeting Microbubbles to Tumor Vasculature , 2007, Clinical Cancer Research.

[9]  Linda Chami,et al.  Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography. , 2006, AJR. American journal of roentgenology.

[10]  Linda Chami,et al.  To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: pilot study using dynamic contrast-enhanced Doppler ultrasound. , 2006, European journal of cancer.

[11]  Mostafa Atri,et al.  New technologies and directed agents for applications of cancer imaging. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Xiaoping Zhou,et al.  A new formalism for the quantification of tissue perfusion by the destruction-replenishment method in contrast ultrasound imaging , 2006, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[13]  David L Buckley,et al.  Imaging vascular physiology to monitor cancer treatment. , 2006, Critical reviews in oncology/hematology.

[14]  Lena Claesson-Welsh,et al.  Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. , 2006, Experimental cell research.

[15]  G. Benea,et al.  Effect of Angiosonography to Monitor Response During Imatinib Treatment in Patients with Metastatic Gastrointestinal Stromal Tumors , 2005, Clinical Cancer Research.

[16]  P. Terrier,et al.  Doppler US with perfusion software and contrast medium injection in the early evaluation of isolated limb perfusion of limb sarcomas: prospective study of 49 cases. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  M. Knopp,et al.  The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations , 2005, British Journal of Cancer.

[18]  S. Griffey,et al.  Contrast-Enhanced Computed Tomography and Ultrasound for the Evaluation of Tumor Blood Flow , 2005, Investigative radiology.

[19]  R. Jain.  Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.

[20]  Nathalie Lassau,et al.  Validation of a New Method for Quantifying In Vivo Murine Tumor Necrosis by Sonography , 2004, Investigative radiology.

[21]  N. Lassau,et al.  Évaluation fonctionnelle et précoce des traitements en cancérologie : intérêt des produits de contraste ultrasonores , 2004 .

[22]  Y. Kono,et al.  Validation of ultrasound contrast destruction imaging for flow quantification. , 2003, Ultrasound in medicine & biology.

[23]  Fabian Kiessling,et al.  A multivessel model describing replenishment kinetics of ultrasound contrast agent for quantification of tissue perfusion. , 2003, Ultrasound in medicine & biology.

[24]  P. Choyke,et al.  Imaging of angiogenesis: from microscope to clinic , 2003, Nature Medicine.

[25]  S. Bonvalot,et al.  [Treatment of local recurrent melanomas by isolated limb perfusion: value of Doppler ultrasonography]. , 2003, Journal de radiologie.

[26]  H. Przuntek,et al.  Contrast Burst Depletion Imaging (CODIM): A New Imaging Procedure and Analysis Method for Semiquantitative Ultrasonic Perfusion Imaging , 2003, Stroke.

[27]  E. Ruoslahti.  Antiangiogenics meet nanotechnology. , 2002, Cancer cell.

[28]  F. Shepherd.  Angiogenesis inhibitors in the treatment of lung cancer. , 2001, Lung cancer.

[29]  A R Padhani,et al.  Challenges for imaging angiogenesis. , 2001, The British journal of radiology.

[30]  M. Leach,et al.  Measuring changes in human tumour vasculature in response to therapy using functional imaging techniques , 2001, British Journal of Cancer.

[31]  Ting-Yim Lee,et al.  Perfusion Mapping Using Computed Tomography Allows Accurate Prediction of Cerebral Infarction in Experimental Brain Ischemia , 2001, Stroke.

[32]  A R Padhani,et al.  Commentary. Are current tumour response criteria relevant for the 21st century? , 2000, The British journal of radiology.

[33]  K W Ferrara,et al.  Evaluation of tumor angiogenesis with US: imaging, Doppler, and contrast agents. , 2000, Academic radiology.

[34]  S. Kaul,et al.  Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. , 2000, Circulation.

[35]  L. Rosen,et al.  Antiangiogenic strategies and agents in clinical trials. , 2000, The oncologist.

[36]  H. Augustin,et al.  Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. , 2000, Cancer research.

[37]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[38]  D Delbeke,et al.  Oncological applications of FDG PET imaging. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[39]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[40]  K. Miles,et al.  CT derived Patlak images of the human kidney. , 1999, The British journal of radiology.

[41]  A R Jayaweera,et al.  Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. , 1998, Circulation.

[42]  N. Ferrara,et al.  The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.

[43]  R K Jain,et al.  Determinants of tumor blood flow: a review. , 1988, Cancer research.

[44]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[45]  Vascular Pattern in Tumours , 1957 .

[46]  H. W. Chalkley,et al.  Vasculae Reactions of Normal and Malignant Tissues in Vivo. I. Vascular Reactions of Mice to Wounds and to Normal and Neoplastic Transplants , 1945 .

[47]  N. Ferrara.  Vascular Endothelial Growth Factor: Basic Biology and Clinical Applications , 2009 .

[48]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[49]  N. Lassau,et al.  [Functional and early evaluation of treatments in oncology: interest of ultrasonographic contrast agents]. , 2004, Journal de radiologie.

[50]  M Van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. , 2000, Journal of the National Cancer Institute.

[51]  M. Bahner,et al.  Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT--initial experience. , 1999, Radiology.

[52]  B. Keyt,et al.  Vascular endothelial growth factor: basic biology and clinical implications. , 1997, EXS.

[53]  N. Simon,et al.  La Pitié-Salpêtrière , 1986 .